FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3163254911> ?p ?o ?g. }

• W3163254911 endingPage "1449" @default.
• W3163254911 startingPage "1441" @default.
• W3163254911 abstract "Abstract Background In the treatment for glioblastoma (GBM), treatment modalities, such as bevacizumab (BEV) and carmustine wafers implants have been approved in Japan since 2013. However, it is unclear whether such a trend in treatment complexity can accelerate treatment centralization. The aim of this study was to reveal the current trend in the treatment of GBM in Japan. Methods We used diagnostic procedure combination (DPC) database to analyze the data of 1,774 patients from 305 institutions between April 2016 and March 2019. To analyze the situations associated with first-line BEV use during concurrent TMZ (temozolomide)-radiotherapy, we compared TMZ alone and TMZ–BEV groups. Results Of the 1,774 patients with GBM, tumor removal by craniotomy was performed in 1,572 (88.6%) patients, and stereotactic biopsy was performed in 156 (8.8%) patients. A total of 1,229 (69.3%) patients underwent radiotherapy, and 1,287 (72.5%) patients underwent chemotherapy. TMZ alone was administered to 878 (68.2%) and TMZ combined with BEV in 381 (29.6%) patients. In the TMZ–BEV group, as compared to the TMZ-alone group, the rate of discharge to home was significantly lower ( P = 0.0044), and the rate of stereotactic biopsy was significantly higher ( P < 0.0001). No significant difference was observed in the distribution of patients between the TMZ alone and TMZ–BEV groups depending on the scale of institution ( P = 0.1240). Conclusion First-line BEV administration seems to be selected properly regardless of the institutional scale. This Japan-wide study of GBM treatment revealed that high level and newly introduced treatments have been steadily generalized in Japanese institutions." @default.
• W3163254911 created "2021-05-24" @default.
• W3163254911 creator A5006442994 @default.
• W3163254911 creator A5013653329 @default.
• W3163254911 creator A5029356365 @default.
• W3163254911 creator A5039308616 @default.
• W3163254911 creator A5054527767 @default.
• W3163254911 creator A5057372919 @default.
• W3163254911 creator A5060272540 @default.
• W3163254911 creator A5065922603 @default.
• W3163254911 creator A5077997942 @default.
• W3163254911 creator A5089237578 @default.
• W3163254911 date "2021-05-11" @default.
• W3163254911 modified "2023-10-17" @default.
• W3163254911 title "Current trend in treatment of glioblastoma in Japan: a national survey using the diagnostic procedure combination database (J-ASPECT study-glioblastoma)" @default.
• W3163254911 cites W1570195799 @default.
• W3163254911 cites W1968930694 @default.
• W3163254911 cites W1973087709 @default.
• W3163254911 cites W1993019581 @default.
• W3163254911 cites W2009298715 @default.
• W3163254911 cites W2096287682 @default.
• W3163254911 cites W2100567246 @default.
• W3163254911 cites W2124736921 @default.
• W3163254911 cites W2125520490 @default.
• W3163254911 cites W2134680580 @default.
• W3163254911 cites W2153471849 @default.
• W3163254911 cites W2156330848 @default.
• W3163254911 cites W2404183613 @default.
• W3163254911 cites W2526116186 @default.
• W3163254911 cites W2556815652 @default.
• W3163254911 cites W2578232660 @default.
• W3163254911 cites W2599750069 @default.
• W3163254911 cites W2620040483 @default.
• W3163254911 cites W2788664433 @default.
• W3163254911 cites W2946720079 @default.
• W3163254911 cites W2980662937 @default.
• W3163254911 cites W3004632817 @default.
• W3163254911 cites W3015123834 @default.
• W3163254911 doi "https://doi.org/10.1007/s10147-021-01929-5" @default.
• W3163254911 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8286941" @default.
• W3163254911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33974184" @default.
• W3163254911 hasPublicationYear "2021" @default.
• W3163254911 type Work @default.
• W3163254911 sameAs 3163254911 @default.
• W3163254911 citedByCount "3" @default.
• W3163254911 countsByYear W31632549112021 @default.
• W3163254911 countsByYear W31632549112022 @default.
• W3163254911 crossrefType "journal-article" @default.
• W3163254911 hasAuthorship W3163254911A5006442994 @default.
• W3163254911 hasAuthorship W3163254911A5013653329 @default.
• W3163254911 hasAuthorship W3163254911A5029356365 @default.
• W3163254911 hasAuthorship W3163254911A5039308616 @default.
• W3163254911 hasAuthorship W3163254911A5054527767 @default.
• W3163254911 hasAuthorship W3163254911A5057372919 @default.
• W3163254911 hasAuthorship W3163254911A5060272540 @default.
• W3163254911 hasAuthorship W3163254911A5065922603 @default.
• W3163254911 hasAuthorship W3163254911A5077997942 @default.
• W3163254911 hasAuthorship W3163254911A5089237578 @default.
• W3163254911 hasBestOaLocation W31632549111 @default.
• W3163254911 hasConcept C126322002 @default.
• W3163254911 hasConcept C143998085 @default.
• W3163254911 hasConcept C2775934546 @default.
• W3163254911 hasConcept C2776194525 @default.
• W3163254911 hasConcept C2776694085 @default.
• W3163254911 hasConcept C2777389519 @default.
• W3163254911 hasConcept C2777802072 @default.
• W3163254911 hasConcept C2778256017 @default.
• W3163254911 hasConcept C2778424827 @default.
• W3163254911 hasConcept C2780140570 @default.
• W3163254911 hasConcept C2780964509 @default.
• W3163254911 hasConcept C502942594 @default.
• W3163254911 hasConcept C509974204 @default.
• W3163254911 hasConcept C71924100 @default.
• W3163254911 hasConceptScore W3163254911C126322002 @default.
• W3163254911 hasConceptScore W3163254911C143998085 @default.
• W3163254911 hasConceptScore W3163254911C2775934546 @default.
• W3163254911 hasConceptScore W3163254911C2776194525 @default.
• W3163254911 hasConceptScore W3163254911C2776694085 @default.
• W3163254911 hasConceptScore W3163254911C2777389519 @default.
• W3163254911 hasConceptScore W3163254911C2777802072 @default.
• W3163254911 hasConceptScore W3163254911C2778256017 @default.
• W3163254911 hasConceptScore W3163254911C2778424827 @default.
• W3163254911 hasConceptScore W3163254911C2780140570 @default.
• W3163254911 hasConceptScore W3163254911C2780964509 @default.
• W3163254911 hasConceptScore W3163254911C502942594 @default.
• W3163254911 hasConceptScore W3163254911C509974204 @default.
• W3163254911 hasConceptScore W3163254911C71924100 @default.
• W3163254911 hasFunder F4320311405 @default.
• W3163254911 hasFunder F4320321945 @default.
• W3163254911 hasFunder F4320334764 @default.
• W3163254911 hasIssue "8" @default.
• W3163254911 hasLocation W31632549111 @default.
• W3163254911 hasLocation W31632549112 @default.
• W3163254911 hasOpenAccess W3163254911 @default.
• W3163254911 hasPrimaryLocation W31632549111 @default.
• W3163254911 hasRelatedWork W1971022287 @default.
• W3163254911 hasRelatedWork W2107163829 @default.
• W3163254911 hasRelatedWork W2165383160 @default.

• next